Elif Sen
Overview
Explore the profile of Elif Sen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baydar Toprak O, Polatli M, Baha A, Kokturk N, Yapar D, Ozkan S, et al.
Medicine (Baltimore)
. 2024 Nov;
103(48):e40483.
PMID: 39612431
Chronic obstructive pulmonary disease (COPD) frequently results in hospital readmission and contributes to increased morbidity and mortality. This multicenter prospective study aimed to identify factors that increase the risk of...
2.
Esendagli D, Kokturk N, Baha A, Yapar D, Ozkan S, Sen E, et al.
BMC Pulm Med
. 2024 Nov;
24(1):590.
PMID: 39609669
Background: Exacerbation is an independent risk factor for chronic obstructive pulmonary disease (COPD)-related morbidity and mortality. Despite optimal care, there may be risk factors that lead to difficulties in managing...
3.
Erol S, Gurun Kaya A, Arslan F, Oz M, Dogan Mulazimoglu D, Isik O, et al.
Diagn Cytopathol
. 2024 May;
52(9):475-479.
PMID: 38690675
Background: In patients with extrathoracic malignancies (ETM), granulomatous lymph adenopathy called sarcoid-like reactions (SLR) can be seen in the regional or draining lymph nodes. We hypothesized that SLR may be...
4.
Celik G, Aydin O, Sen E, Demir T, Gemicioglu B, Kiyan E, et al.
Tuberk Toraks
. 2024 Apr;
72(1):25-36.
PMID: 38676592
Introduction: Patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) have a greater disease burden than those with COPD or asthma alone. In this study, it was aimed to determine...
5.
Dogan Mulazimoglu D, Bilgin B, Ayoz S, Arslan F, Sen E
Tuberk Toraks
. 2024 Apr;
72(1):16-24.
PMID: 38676591
Introduction: The relationship between comorbidities and chronic obstructive pulmonary disease (COPD) is two-sided. As the number of comorbidities increases, frequency of acute exacerbations of COPD (AECOPD) consequently increases. Comorbidity indices...
6.
Price D, Henley W, Cancado J, Fabbri L, Kerstjens H, Papi A, et al.
Pragmat Obs Res
. 2024 Jan;
15:1-16.
PMID: 38274639
Background: Combined ICS and long-acting bronchodilators (LABD) more effectively reduce COPD exacerbations than LABD therapy alone. Corticosteroid-related adverse effects, including pneumonia, limit ICS use. Previous data suggest this risk is...
7.
Arkan Demiral G, Sen E
Tuberk Toraks
. 2022 Dec;
70(4):349-357.
PMID: 36537092
Introduction: It is known that there is a relationship between severe exacerbations of chronic obstructive pulmonary disease(COPD) requiring hospitalization with loss of forced expiratory volume in one second (FEV1), impaired...
8.
Gunen H, Kokturk N, Nayci S, Ozkaya S, Yildiz B, Turan O, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Aug;
17:1883-1895.
PMID: 36003323
Purpose: GOLD 2019 proposed a novel treatment decision tool for follow-up based on the predominant trait (exacerbation or dyspnea) of patients, alongside treatment escalation and de-escalation strategies. This study was...
9.
Gurun Kaya A, Ciledag A, Erol S, Oz M, Dogan Mulazimoglu D, Isik O, et al.
Aging Clin Exp Res
. 2022 Apr;
34(4):937.
PMID: 35451736
No abstract available.
10.
Price D, Henley W, Cancado J, Fabbri L, Kerstjens H, Papi A, et al.
Int J Chron Obstruct Pulmon Dis
. 2022 Feb;
17:355-370.
PMID: 35210765
Background: Inhaled corticosteroids (ICS) afford therapeutic benefits in some COPD patients, but their widespread use is cautioned due to an increased risk of developing pneumonia. Subclass variations exist, and the...